 |
PDBsum entry 2etz
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Transferase
|
 |
|
Title:
|
 |
The nmr minimized average structure of the itk sh2 domain bound to a phosphopeptide
|
|
Structure:
|
 |
Tyrosine-protein kinase itk/tsk. Chain: a. Fragment: sh2 domain. Synonym: t-cell-specific kinase, il-2-inducible t-cell kinase, kinase emt, kinase tlk, itk. Engineered: yes. Lymphocyte cytosolic protein 2 phosphopeptide fragment. Chain: b. Fragment: phosphopeptide fragment sequence database residues 143-148.
|
|
Source:
|
 |
Mus musculus. House mouse. Organism_taxid: 10090. Gene: itk, emt, tlk, tsk. Expressed in: escherichia coli bl21(de3). Expression_system_taxid: 469008. Synthetic: yes. Other_details: the sequence of the peptide is naturally found in mus musculus (mouse).
|
|
NMR struc:
|
 |
1 models
|
 |
|
Authors:
|
 |
M.Sundd,E.V.Pletneva,D.B.Fulton,A.H.Andreotti
|
Key ref:
|
 |
E.V.Pletneva
et al.
(2006).
Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
J Mol Biol,
357,
550-561.
PubMed id:
DOI:
|
 |
|
Date:
|
 |
|
27-Oct-05
|
Release date:
|
07-Feb-06
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
Q03526
(ITK_MOUSE) -
Tyrosine-protein kinase ITK/TSK from Mus musculus
|
|
|
|
Seq: Struc:
|
 |
 |
 |
625 a.a.
108 a.a.*
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
*
PDB and UniProt seqs differ
at 1 residue position (black
cross)
|
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.2.7.10.2
- non-specific protein-tyrosine kinase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
L-tyrosyl-[protein] + ATP = O-phospho-L-tyrosyl-[protein] + ADP + H+
|
 |
 |
 |
 |
 |
L-tyrosyl-[protein]
|
+
|
ATP
|
=
|
O-phospho-L-tyrosyl-[protein]
|
+
|
ADP
|
+
|
H(+)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Mol Biol
357:550-561
(2006)
|
|
PubMed id:
|
|
|
|
|
| |
|
Molecular details of Itk activation by prolyl isomerization and phospholigand binding: the NMR structure of the Itk SH2 domain bound to a phosphopeptide.
|
|
E.V.Pletneva,
M.Sundd,
D.B.Fulton,
A.H.Andreotti.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The Src homology 2 (SH2) domain of interleukin-2 tyrosine kinase (Itk) is a
critical component of the regulatory apparatus controlling the activity of this
immunologically important enzyme. To gain insight into the structural features
associated with the activated form of Itk, we have solved the NMR structure of
the SH2 domain bound to a phosphotyrosine-containing peptide (pY) and analyzed
changes in trans-hydrogen bond scalar couplings ((3h)J(NC')) that result from pY
binding. Isomerization of a single prolyl imide bond in this domain is
responsible for simultaneous existence of two distinct SH2 conformers. Prolyl
isomerization directs ligand recognition: the trans conformer preferentially
binds pY. The structure of the SH2/pY complex provides insight into the ligand
specificity; the BG loop in the ligand-free trans SH2 conformer is pre-arranged
for optimal contacts with the pY+3 residue of the ligand. Analysis of (3h)J(NC')
couplings arising from hydrogen bonds has revealed propagation of structural
changes from the pY binding pocket to the CD loop containing conformationally
heterogeneous proline as well as to the alphaB helix, on the opposite site of
the domain. These findings offer a structural framework for understanding the
roles of prolyl isomerization and pY binding in Itk regulation.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 2.
Figure 2. NMR structure of the Itk SH2 domain bound to the
Ac-ADpYEPP-NH[2] phosphopeptide. (a) The 20 lowest energy
structures of the Itk SH2/ADpYEPP complex. The peptide ligand is
shown in red and the SH2 domain in turquoise. Backbone heavy
atoms within the secondary structural elements over the entire
SH2 sequence were used for superpositions. (b) Ribbon diagram of
the energy minimized average structure of the Itk
SH2/phosphopeptide complex. (The view is identical with that
shown in (a).) Regular secondary structural elements and loop
regions are labeled. The location of Pro287 within the CD loop
is indicated. The phosphopeptide ligand (Ac-ADpYEPP-NH[2]) is
red and the phosphotyrosine (pY) and proline residue three
positions C-terminal (pY+3) are labeled. In both (a) and (b) the
first two residues of the phosphopeptide (AD) are not included
for clarity. No NOEs are observed between this region of the
peptide and the Itk SH2 domain.
|
 |
Figure 3.
Figure 3. (a) Superposition of the minimized average
structures of the cis SH2 domain (orange), the trans SH2 domain
(light blue) and the phospholigand-bound SH2 domain (dark blue).
The phospholigand is shown in red and the pY and pY+3 residues
are labeled. The BG loop is indicated and the arrow shows the
shift in position of the alpha carbon atom of Leu329 that
accompanies isomerization of Pro287 from the cis to trans
conformations. The structure of the BG loop for the
phospholigand-bound SH2 domain (dark blue) is similar to that of
BG loop in the ligand-free trans domain (light blue). (b)
Superposition of the lowest energy structures of the Itk cis SH2
domain (20 structures), the trans SH2 domain (20 structures) and
the SH2/phosphopeptide complex (20 structures). Colors
correspond to those in (a). The ensemble of structures indicates
that the BG loop in the cis SH2 structure (orange) adopts a
range of conformations that differ from the conformational
preferences of both the trans SH2 domain and the phospholigand
bound SH2 domain. For both (a) and (b) backbone heavy atoms
within the secondary structural elements were used for
superpositions.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from Elsevier:
J Mol Biol
(2006,
357,
550-561)
copyright 2006.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
T.Kaneko,
S.S.Sidhu,
and
S.S.Li
(2011).
Evolving specificity from variability for protein interaction domains.
|
| |
Trends Biochem Sci,
36,
183-190.
|
 |
|
|
|
|
 |
A.Severin,
R.E.Joseph,
S.Boyken,
D.B.Fulton,
and
A.H.Andreotti
(2009).
Proline isomerization preorganizes the Itk SH2 domain for binding to the Itk SH3 domain.
|
| |
J Mol Biol,
387,
726-743.
|
 |
|
|
|
|
 |
J.E.Smith-Garvin,
G.A.Koretzky,
and
M.S.Jordan
(2009).
T cell activation.
|
| |
Annu Rev Immunol,
27,
591-619.
|
 |
|
|
|
|
 |
K.Huck,
O.Feyen,
T.Niehues,
F.Rüschendorf,
N.Hübner,
H.J.Laws,
T.Telieps,
S.Knapp,
H.H.Wacker,
A.Meindl,
H.Jumaa,
and
A.Borkhardt
(2009).
Girls homozygous for an IL-2-inducible T cell kinase mutation that leads to protein deficiency develop fatal EBV-associated lymphoproliferation.
|
| |
J Clin Invest,
119,
1350-1358.
|
 |
|
|
|
|
 |
N.Sahu,
and
A.August
(2009).
ITK inhibitors in inflammation and immune-mediated disorders.
|
| |
Curr Top Med Chem,
9,
690-703.
|
 |
|
|
|
|
 |
R.E.Joseph,
and
A.H.Andreotti
(2009).
Conformational snapshots of Tec kinases during signaling.
|
| |
Immunol Rev,
228,
74-92.
|
 |
|
|
|
|
 |
R.E.Joseph,
A.Severin,
L.Min,
D.B.Fulton,
and
A.H.Andreotti
(2009).
SH2-dependent autophosphorylation within the Tec family kinase Itk.
|
| |
J Mol Biol,
391,
164-177.
|
 |
|
|
|
|
 |
U.Weininger,
R.P.Jakob,
B.Eckert,
K.Schweimer,
F.X.Schmid,
and
J.Balbach
(2009).
A remote prolyl isomerization controls domain assembly via a hydrogen bonding network.
|
| |
Proc Natl Acad Sci U S A,
106,
12335-12340.
|
 |
|
|
|
|
 |
M.S.Jordan,
J.E.Smith,
J.C.Burns,
J.E.Austin,
K.E.Nichols,
A.C.Aschenbrenner,
and
G.A.Koretzky
(2008).
Complementation in trans of altered thymocyte development in mice expressing mutant forms of the adaptor molecule SLP76.
|
| |
Immunity,
28,
359-369.
|
 |
|
|
|
|
 |
N.Isakov
(2008).
A new twist to adaptor proteins contributes to regulation of lymphocyte cell signaling.
|
| |
Trends Immunol,
29,
388-396.
|
 |
|
|
|
|
 |
A.Zhang,
and
A.D.Schlüter
(2007).
Multigram solution-phase synthesis of three diastereomeric tripeptidic second-generation dendrons based on (2S,4S)-, (2S,4R)-, and (2R,4S)-4-aminoprolines.
|
| |
Chem Asian J,
2,
1540-1548.
|
 |
|
|
|
|
 |
D.Hamelberg,
T.Shen,
and
J.A.McCammon
(2007).
A proposed signaling motif for nuclear import in mRNA processing via the formation of arginine claw.
|
| |
Proc Natl Acad Sci U S A,
104,
14947-14951.
|
 |
|
|
|
|
 |
D.Wildemann,
B.Hernandez Alvarez,
G.Stoller,
X.Z.Zhou,
K.P.Lu,
F.Erdmann,
D.Ferrari,
and
G.Fischer
(2007).
An essential role for Pin1 in Xenopus laevis embryonic development revealed by specific inhibitors.
|
| |
Biol Chem,
388,
1103-1111.
|
 |
|
|
|
|
 |
K.P.Lu,
G.Finn,
T.H.Lee,
and
L.K.Nicholson
(2007).
Prolyl cis-trans isomerization as a molecular timer.
|
| |
Nat Chem Biol,
3,
619-629.
|
 |
|
|
|
|
 |
P.Sarkar,
C.Reichman,
T.Saleh,
R.B.Birge,
and
C.G.Kalodimos
(2007).
Proline cis-trans isomerization controls autoinhibition of a signaling protein.
|
| |
Mol Cell,
25,
413-426.
|
 |
|
|
|
|
 |
K.C.Huang,
H.T.Cheng,
M.T.Pai,
S.R.Tzeng,
and
J.W.Cheng
(2006).
Solution structure and phosphopeptide binding of the SH2 domain from the human Bruton's tyrosine kinase.
|
| |
J Biomol NMR,
36,
73-78.
|
 |
|
PDB code:
|
 |
|
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |